News Eagle Pharmaceuticals to Present CAL02 Trial in Progress at the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Staff September 11, 2023 Iframe sync Post navigation Previous: New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral ClearanceNext: XORTX Announces Participation at Upcoming Investor Conferences More Stories Coronavirus COVID-19 Diagnostics Healthcare Mental Health News Patient Care Predictmedix AI Inc. Announces Proposed Name Change to QScreen AI Inc., Pioneering the Fusion of Quantum Computing and AI to Transform Healthcare Staff January 12, 2026 Coronavirus COVID-19 Diagnostics Healthcare Mental Health News Patient Care Predictmedix AI Inc. Announces Proposed Name Change to QScreen AI Inc., Pioneering the Fusion of Quantum Computing and AI to Transform Healthcare Staff January 12, 2026 Autism Brain Cancer Healthcare Medicaid Medicare Menopause Neurology News Pharmaceutical CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz’s Team and an “Evidence Sprint 2026” Focused on Grants, Research and Clinical Evidence Staff January 12, 2026
